Shark Tank investor Kevin O'Leary debunks the myth of relentless startup grind, calling the 18-hour workday 'stupid.' He warns that sleep d...

Pregabalin, a nerve pain medication, now faces stricter controls. The Union health ministry has moved it to Schedule H1. This change aims t...

Selena Gomez's famous quote about Cinderella offers a powerful message on letting go. It highlights the importance of not looking back to f...

Heart attacks are often misunderstood. Warning signs can appear days or weeks before. Many people believe dangerous myths about symptoms, r...

Indian mothers often neglect their health, leading to chronic illnesses like joint pain, thyroid issues, diabetes, and hypertension in midd...

The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...

DR Sudhir Kumar, a Hyderabad-based neurologist at Apollo Hospitals, revealed a case in which a woman experienced strange pain in her legs f...

Applegate has been candid about her diagnosis and how it has affected her life. Since publicly confirming her condition in August 2021, she...

A recent study reveals headaches significantly impact daily life in Delhi-NCR. Approximately 26% of adults need professional help for heada...

A recent study led by researchers at the University of California Los Angeles (UCLA) suggests that emotional awareness and expression thera...

Commonly prescribed painkillers may also cause sleep deprivation.

Conditions such as back pain, diabetes and heart disease may be at an increased risk of committing suicide.

Suicide is a complex issue and therefore prevention efforts require coordination and collaboration among multiple sectors of society.

Mostly, we deal with pain by popping pain killers without giving it much thought. Others usually just wait for it to subside on its own.

Fibromyalgia is a common ailment characterised by chronic widespread pain and a heightened and painful response to pressure.

Glenmark Pharmaceuticals said its novel chemical entity for potential treatment of chronic inflammatory disorders is entering human trials.

The corporate sector as well as the government should chip in to scale up financing in primary healthcare.